Arthritis & Rheumatology - McMaster Experts

publication venue for

An Advanced Physiotherapist Practitioner Model of Care Is Ideally Suited to Address Workforce Concerns in Pediatric Rheumatology: A Retrospective Chart Review 2023
Developing Standard Improvement Curves for Disease Activity, Pain and Quality of Life in Children with Newly Diagnosed Juvenile Idiopathic Arthritis: Results from the CAPRI Registry 2023
A Cross-Sectional Description of Physical Activity (PA) in Children with Juvenile Idiopathic Arthritis (JIA): The LEAP Study (Linking Exercise, Activity, and Pathophysiology in Canadian Children with Arthritis) 2022
Adult Rheumatologists' Knowledge, Comfort Level, and Perceived Barriers in Supporting Newly Transitioned Youth with Chronic Rheumatic Diseases in Canada 2022
Associations of Nociceptive Dysfunction with Physical Activity in Knee Osteoarthritis: The Multicenter Osteoarthritis Study 2022
Characteristics and Outcomes of Participants with and Without Diffuse Alveolar Hemorrhage in the Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis (PEXIVAS) Trial 2022
Characteristics of Transitioning JIA Patients: Who Is Arriving on the Adult Rheumatologists' Doorsteps? 2022
Exploring Canadian Patient Experiences of Living with Lupus Nephritis (LN) 2022
Long-term Cardiovascular Disease and Mortality Following Kawasaki Disease in Childhood: A Systematic Review and Meta-analysis 2022
Markers of Neutrophil Activation in Patients with ANCA-associated Vasculitis and Large-vessel Vasculitis 2022
More Meticulously Following Treat-to-target in RA Does Not Lead to Less Radiographic Progression: A Longitudinal Analysis in BIODAM 2022
Outcome Measures in Patients with Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study 2022
Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications 2022
The Association Between Age of Diagnosis and Disease Characteristics and Damage in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 2022
Transition Readiness Before versus After Adolescents with Rheumatic Disease Transition to Adult Care 2022
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids. 2022
A Comparison of Cardiovascular Health Indicators in Children with Juvenile Idiopathic Arthritis Who Meet and Do Not Meet the Physical Activity Guidelines 2021
Consensus Approach to a Treat to Target Strategy in Juvenile Idiopathic Arthritis Care: Report from the 2020 Pediatric Rheumatology Care and Outcomes Improvement Network Consensus Conference 2021
Determinants of Accessing Social and News Media and Experiencing Negative Impacts During COVID-19 in an International SLE Sample 2021
Health Information Use by SLE Patients Pre and During COVID-19 2021
Healthcare Utilization and Costs Following Kawasaki Disease in Ontario, Canada 2021
Impact of the COVID-19 Pandemic on Presentation of JIA to Pediatric Rheumatology Care in Canada 2021
Long-term Cardiovascular Disease and Mortality Following Kawasaki Disease in Childhood: A Systematic Review 2021
Mind the Gap: The Experience of Adolescents in a Rheumatology Transition Clinic 2021
Neurologic Involvement in ANCA-associated Vasculitis: Data from Multicenter Longitudinal Observational Study 2021
Neutrophil Extracellular Trap Formation in Patients with Vasculitis 2021
Pain Severity and Interference in Adult Autoimmune Inflammatory Myopathies 2021
Predictors of ILD Development and Timing of Onset in Systemic Sclerosis: A Canadian Cohort 2021
Relation of Depressive Symptoms to Alterations in Conditioned Pain Modulation in Knee Osteoarthritis: The Multicenter Osteoarthritis Study (MOST) 2021
Role of CD4+T Cells in the Pathogenesis of RA: Immunization with Citrullinated T Cell Epitopes Is Sufficient to Induce Immunological and Clinical Manifestations of Arthritis in DR4-Transgenic Mice 2021
Safety and Efficacy of Denosumab vs Risedronate in Patients with Glucocorticoid-Induced Osteoporosis and Rheumatoid Arthritis 2021
Scleroderma Presentation in the Canadian Scleroderma Research Group Indigenous Population 2021
The Rheumatology Workforce in Canada: Results of the Workforce and Wellness Survey 2021
Transcriptional Regulation of Synovial Macrophages in the Aging Joint 2021
CLEC12A Expression as a Potential Predictor of Disease Activity in Early Rheumatoid Arthritis 2020
Care Gap in Patients with Systemic Sclerosis with CXR Findings Suggestive of Fibrosis 2020
Characteristics of Adult Patients with Rheumatic Diseases During the COVID-19 Pandemic: Data from an International Patient Survey 2020
Do Weight-bearing versus Non-weight-bearing Pain Reflect Different Pain Mechanisms in Knee Osteoarthritis?: The Multicenter Osteoarthritis Study 2020
Goal-Setting Improves Transition Readiness in Adolescents with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus 2020
Impact of the COVID-19 Pandemic Among Children with Rheumatic Diseases from Around the Globe 2020
Impact of the COVID-19 Pandemic on Racial and Ethnic Minority Groups Diagnosed with Rheumatic Diseases 2020
Late Cardiovascular Outcomes in Children with Kawasaki Disease: A Population-based Cohort Study 2020
Modeling the Effects of Covid-19 Protective Behaviors and Healthcare Delivery on the Health of Patients with Rheumatic Disease 2020
New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network 2020
Prevalence of Thyroid Disease Among Patients with Vasculitis 2020
Ready or Not? Measuring Readiness for Transition to Adult Care in Adolescents with JIA & jSLE 2020
Relation of Pain Mechanisms to Development of Knee Pain in Osteoarthritis: The Multicenter Osteoarthritis Study 2020
Rheumatologists' Attitudes Toward Palliative Care and Medical Assistance in Dying 2020
Systematic Review of Effectiveness Outcomes Reported in Rheumatology Transition Literature 2020
Systemic Sclerosis Progression and Pregnancy: A Hopeful Message from the Canadian Scleroderma Registry Database 2020
Thyroid Disease in Patients with ANCA-Associated Vasculitis 2020
Implementing Treat to Target Approach in the Care of Juvenile Idiopathic Arthritis Across a Network of Pediatric Rheumatology Centers 2020
Kawasaki Disease in Ontario Children from 1995-2017: A Population-based Descriptive Analysis 2020
New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network 2020
Transition from Pediatric to Adult Rheumatology: The Clinician as a Fundamental Ally 2020
Antimalarial Drug Shortages During the COVID-19 Pandemic: Results from the Global Rheumatology Alliance Patient Experience Survey [abstract]. 2020
Assessing Perceptions, Barriers, and Preferences to Exercise in Patients with Systemic Lupus Erythematosus 2019
Assessments of Quality of Life in Patients with Eosinophilic Granulomatosis with Polyangiitis 2019
Clinical Manifestations of Patients with Eosinophilic Granulomatosis with Polyangiitis in a Large North American Cohort 2019
Clinical Presentation and Treatment of Oligoarticular Psoriatic Arthritis in Canada: High Frequency of Smaller Joint Involvement 2019
Comparison of Arterial Patterns of Disease in Takayasu's Arteritis and Giant Cell Arteritis 2019
Comparison of Patient Self-reported Data to Physician-driven Cohorts in Patients with Eosinophilic Granulomatosis with Polyangiitis 2019
Designing and Testing Treat to Target as a New Care Model in JIA Across a Network of Pediatric Rheumatology Centers 2019
Distinct Characteristics of the Gut Microbiome of Patients with Systemic Sclerosis and Small Intestinal Bacterial Overgrowth 2019
Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moderate Chronic Kidney Disease 2019
Nortriptyline in Knee Arthritis (Nortika): A Randomised Controlled Double Blind Trial of Nortriptyline for Pain in Knee Osteoarthritis 2019
Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry 2019
Rationalizing the Use of MRI of the Scalp Arteries in the Diagnosis of Giant Cell Arteritis Through Multivariable Predictive Modelling 2019
The Cumulative Burden of Damage for Patients with Eosinophilic Granulomatosis with Polyangiitis 2019
The Relation of Pain Sensitization and Conditioned Pain Modulation to Pain Patterns in Knee Osteoarthritis: The Multicenter Osteoarthritis Study 2019
Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis 2018
Candidate Biomarkers in ANCA-Associated Vasculitis Identified Using a Proteomic Approach 2018
Construct Validation of the Screening for Inflammatory Pain in the Lower Back Questionnaire: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort 2018
Current Factors Associated with Insufficient Vitamin D Status in Patients with Osteoporosis 2018
Discovery and Validation of Novel Disease Subsets in 806 Patients with Takayasu's Arteritis across Four International Cohorts 2018
Evaluating Disease Activity Outcomes for Juvenile Idiopathic Arthritis across the Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) 2018
Greater BMD Gains with Denosumab Vs Risedronate in Glucocorticoid-Treated Subjects: Results from the Final 24-Month Analysis of a Randomized, Double-Blind, Double-Dummy Study 2018
How Are Patients with Chronic Musculoskeletal Pain Conditions Being Managed Initially in the US? 2018
Impact of Guselkumab Versus Placebo and Adalimumab on Patient Reported Outcomes in Patients with and without Psoriatic Arthritis in a Phase 3 Pivotal Psoriasis Study 2018
Longitudinal Changes in Relative Market Share Proportions of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Descriptive Data from the Ontario Best-Practice Research Initiative Database 2018
Plasma iC3b Level As a Biomarker of Disease Relapse in ANCA-Associated Vasculitis 2018
Predictors of Survival of Adalimumab Treatment in the Management of Ankylosing Spondylitis and Psoriatic Arthritis in Canadian Routine Care 2018
Recurrent Thrombosis in Patients with Antiphospholipid Antibodies Following an Initial Venous or Arterial Thromboembolic Event 2018
Regional and Temporal Variation in the Baseline Profile of Ankylosing Spondylitis Patients Initiating Adalimumab Following Failure of Non-Biologic Treatment in Canadian Routine Care 2018
Screening for Tuberculosis before Initiating TNF Inhibitors: How Well Do We Do? a Nationwide Experience 2018
Screening of Patients with Adult-Onset Idiopathic Polyarteritis Nodosa for Deficiency of Adenosine Deaminase 2 2018
Sub-Clinical Disease Activity in the Feet of Patients with Early Rheumatoid Arthritis: What Clinical Assessments Miss 2018
Subgroup Analysis of the Effect of Denosumab Compared with Risedronate on Percentage Change in Lumbar Spine Bone Mineral Density at 24 Months in Glucocorticoid-Treated Individuals 2018
TNF Inhibitor Dose Tapering in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis 2018
The Effects of Plasma Exchange and Reduced-Dose Glucocorticoids during Remission-Induction for Treatment of Severe ANCA-Associated Vasculitis 2018
The Role of Inflammation in the Evolution of MRI Erosions in the Feet of Patients with Early RA 2018
The Trajectory of Grade 1 Erosions in the Feet of Patients with Early RA 2018
The Use of Musculoskeletal Ultrasound to Assess Remission in Patients with Rheumatoid Arthritis 2018
Time to Discontinuation of Biologic Therapy By Mechanism of Action in Rheumatoid Arthritis: Results from a Rheumatoid Arthritis Cohort 2018
What Is the Impact of Imaging on Diagnostic Ascertainment of Patients Presenting with Undiagnosed Back Pain in Routine Practice and the Impact of Central Reading? Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort 2018
A Randomized Controlled Trial (RCT) of an Internet-Based Self-Management Program for Adolescents with Juvenile Idiopathic Arthritis (JIA) 2017
Adding Ultrasound to the Treat-to-Target Strategy Shows No Benefit in Achievement of Remission: Results from the Biodam Cohort 2017
Damage and Predictors of Damage in Takayasu's Arteritis 2017
Discrepancies between Clinical- and Imaging-Based Assessments of Disease Activity in Takayasu's Arteritis 2017
Economic Evaluation of Damage Accrual in a Nationwide Canadian SLE Cohort 2017
Favourable Changes in Power Doppler Scores in the Feet over 1-Year in an Early Rheumatoid Arthritis Cohort: The Role of Rheumatoid Factor and Anti-Citrullinated Protein Antibody 2017
GRADE-Based Recommendations for the Diagnosis and Monitoring of Systemic Lupus Erythematosus in Canada 2017
Identifying Pain Susceptibility Phenotypes in Those Free of Knee Pain with or at Risk for Knee Osteoarthritis and Their Relation to Developing Knee Pain 2017
Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World 2017
Is Earlier Golimumab Treatment Initiation in Psa and As Patients Associated with Improved Outcomes? 2017
Ixekizumab Improves Patient-Reported Outcomes through 52 Weeks in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to Tumor Necrosis Factor-Inhibitors 2017
Knowledge Translation in Juvenile Idiopathic Arthritis in Canada: A Focus on Parents of Children with JIA 2017
Longitudinal Angiographic Findings in Patients with Takayasu's Arteritis 2017
Markers of Inflammation and Patient-Reported Measures As Predictors of Relapse in Giant Cell Arteritis 2017
One Year Changes in Ultrasound Findings in the Feet Are Associated with Patient Reported Outcomes but Not Clinical Examination: a Prospective Observational Study of Patients with Early Rheumatoid Arthritis 2017
Pituitary Disease and Granulomatosis with Polyangiitis: A Collaborative Canadian Case Series and Review of the Literature 2017
Predictors of Long-Term Retention of Methotrexate and Other Dmards with Golimumab in Rheumatoid Arthritis and Psoriatic Arthritis: An Analysis from a Prospective, Observational Registry 2017
Pulmonary Manifestations in Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Multicenter Cohort Analysis 2017
Safety and Effectiveness of Ustekinumab for the Treatment of Psoriatic Arthritis over a 6 Month Period 2017
Scope and Consistency of Adherence Related Outcomes in Randomized Controlled Trials of Interventions for Improving Medication Adherence 2017
Stability of Two Short Medication Adherence Questionnaires over Time for Followup in Patients with Rheumatoid Arthritis 2017
The Effect on Health-Related Quality of Life of Treatment for Remission Maintenance in ANCA-Associated Vasculitis Beyond 18 Months 2017
The Placebo-Controlled Fracture Study in Postmenopausal Women with Osteoporosis: The Foundation Effect of Rebuilding Bone with One Year of Romosozumab Leads to Continued Lower Fracture Risk after Transition to Denosumab 2017
The Steroid Tapering in ANCA Vasculitis Evaluation Study (STAVE) 2: A Systematic Review and Meta-Analysis 2017
Urinary Epidermal Growth Factor and Monocyte Chemoattractant Protein-1 As Biomarkers of Renal Involvement in ANCA-Associated Vasculitis 2017
An Internet-based Self-management Program for Adolescents with Juvenile Idiopathic Arthritis - A Randomized Controlled Trial 2017
Exploring the role of pediatric rheumatologists in the diagnosis and management of autoimmune encephalitis 2017
Knowledge Translation in Juvenile Idiopathic Arthritis Research in Canada: A Focus on Pediatric Rheumatologists and Allied Health Professionals 2017
Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Improvement on Quality Measures for Children with Juvenile Idiopathic Arthritis 2017
Reliability of the Physician Global Assessment Scores for Determination of Disease Activity Status within the Pediatric Rheumatology Care and Outcomes Improvement Network 2017
Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome 2017
A Qualitative Study Exploring Participants' Perception of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Maintain Employment 2016
A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Takayasu's Arteritis 2016
Anatomical Patterns Suggest the Involvement of Biomechanical Stress in the Pathogenesis of Erosions in Rheumatoid Arthritis 2016
Arterial Lesions in Giant Cell Arteritis 2016
Assessing Agreement Among Measures of Inflammation Detected on Magnetic Resonance Imaging, Ultrasound and Clinical Findings in the Feet of Patients with Early Rheumatoid Arthritis 2016
Assessing Bone Erosions in the Metatarsophalangeal Joints of Patients with Early Rheumatoid Arthritis: a Comparison Between MRI and Ultrasound 2016
Association of Sex, Race and Ethnicity on Disease Outcomes in Juvenile Idiopathic Arthritis Patients 2016
Canadian Study of Outcomes in Adalimumab (HUMIRA®) Patients with Support for Adherence - Results from the Companion Study 2016
Comparison of Infliximab Immunogenicity in Inflammatory Arthritis Versus Inflammatory Bowel Disease Patients in Routine Clinical Practice 2016
Conceptualizing the Life Course in the Employment Experiences of Working-Aged Adults with Arthritis: A Qualitative Study 2016
Do Specific Entheseal Points in Spa Patients Impact Patient Reported Outcomes? Implications for Clinical Practice 2016
Effect of BMI on Symptoms and Outcomes in Juvenile Idiopathic Arthritis Patients 2016
Effect of Denosumab Compared with Risedronate in Glucocorticoid-Treated Individuals: Results from the 12-Month Primary Analysis of a Randomized, Double-Blind, Active-Controlled Study 2016
Effects of a Web-Based Patient Decision Aid on Biologics for Rheumatoid Arthritis: A Proof-of-Concept Study 2016
Fatigue and Physical Functioning in Patients with Giant Cell Arteritis 2016
Fracture Risk Reduction with Romosozumab: Results of a Phase 3 Study in Postmenopausal Women with Osteoporosis 2016
Health-Related Quality of Life in Giant Cell Arteritis 2016
Impact of HLA-B27 on Patient Profile and Treatment Response in As Patients Treated with Anti-TNF in Canadian Real-World 2016
Late-Onset Relapse in Patients with Systemic Vasculitis 2016
Long-Term Stability of the 5-Item Compliance Questionnaire Rheumatology As a Measure of Adherence in Patients with Rheumatoid Arthritis 2016
Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy 2016
New Insights into the Pathogenesis of Giant Cell Arteritis through a Genome-Wide Association Study 2016
Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Improvement on Quality Measures for Children with Juvenile Idiopathic Arthritis 2016
Rho Kinase Ezpression in Giant Cell Arteritis: Validating Perm Intensity Score As a Method of Increasing Sensitivity of Temporal Artery Biopsy 2016
Risk Factors for Osteonecrosis in Systemic Lupus Erythematosus: A Systematic Review 2016
The HAQ Reversible and Irreversible Components Measuring Function in Rheumatoid Arthritis 2016
The Utility of Patient-Reported Outcomes in Predicting Disease Activity in Patients with Takayasu's Arteritis 2016
Utility of Measurements of Urinary Soluble CD163 & MCP-1 in the Identification of Subtle Renal Flares in ANCA-Associated Vasculitis 2016
What Is the Relationship Between Early Metacarpophalangeal Erosions on MRI and Joint Pain in Rheumatoid Arthritis? 2016
A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for the Treatment of Giant Cell Arteritis 2015
AMP-Activated Protein Kinase As an Anti-Inflammatory Target for Methotrexate 2015
Administration of Patient Reported Outcome Measurement Information System (PROMIS) Instruments By Computer Adaptive Testing in Patients with Systemic Vasculitis 2015
Anticytokine Autoantibody Profiling in Five Types of Systemic Vasculitis 2015
Calf Muscle Adiposity Is Associated with Impaired Physical Performance in Knee OA 2015
Damage Assessment in Giant Cell Arteritis 2015
Damage Assessment in Takayasu's Arteritis 2015
Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis? 2015
Fecal Incontinence and Association with Bowel Dysfunction in Systemic Sclerosis: A Canadian Multicenter Study 2015
Is Treat-to-Target Really Working? a Longitudinal Analysis in Biodam 2015
Measuring the Rheumatologist Workforce in Canada: Preliminary Results of the Stand up and be Counted Survey 2015
No Sex Bias in the Escalation of Therapy in the Treatment of Early Inflammatory Arthritis 2015
Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting 2015
Persistence with Biologic Monotherapy in Comparison with Combination Therapy with Disease-Modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis; Results from a Rheumatoid Arthritis Cohort 2015
Primary Care Management of Patients with Rheumatic Diseases Prior to Rheumatologist Consultation 2015
Proof of Concept Study of the Arthritis Health Journal: An Online Tool to Promote Self-Monitoring in People with Rheumatoid Arthritis (RA) 2015
Quantifying the Delays to Rheumatologist Consultation and Treatment Among Patients with Systemic Inflammatory Rheumatic Diseases 2015
Resident's Guide to Pediatric Rheumatology Mobile App: Assessing Enablers and Barriers of Use through Qualitative Focus Groups 2015
Safety and Tolerability of Pirfenidone in Patients with Systemic Sclerosis Interstitial Lung Disease 2015
Test-Retest Reliability of the 5-Item Compliance Questionnaire Rheumatology and Factors Influencing Its Assessment of Adherence in Patients with Rheumatoid Arthritis 2015
The Effect of Widespread Pain on Incident Knee Pain and Knee Osteoarthritis: The Multicenter Osteoarthritis (MOST) Study 2015
Using Exome Sequencing to Identify Novel Genetic Associations with Granulomatosis with Polyangiitis Susceptibility 2015
A Novel Approach to Assess Wait-Times to Rheumatologists 2014
Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study. 2014
An Immunochip Study Confirms a Strong Contribution of HLA Class I and II Genes in the Susceptibility to Giant Cell Arteritis. 2014
Assessing the Validity and Reliability of a Novel MRI Semi-Automated Algorithm for Quantifying Bone Loss in the Hand. 2014
Biomarkers of Disease Activity in Vasculitis. 2014
Bone Erosions in Patients with RA: Exploring the Impact of the Anatomy of Interest on the Relationship Between MRI and X-Ray Erosion Detection. 2014
Changes in Subject Characteristics in the Denosumab Pivotal Fracture Trial and Its Extension for up to 8 Years. 2014
Genetic Susceptibility Loci of Idiopathic Interstitial Pneumonitis Do Not Represent Risk for Systemic Sclerosis. 2014
How Does Non-Compliance to Prolia® (DENOSUMAB) Impact the Change in Bone Mineral Density (BMD) in Osteoporotic Patients? 2014
Impact of Corticosteroid Use on Remission Sustainability and Infection Rates Among Rheumatoid Arthritis Patients in Remission While on Infliximab: Treatment Implications Based on a Real-World Canadian Population. 2014
Impact of Failure to Adhere to Treat-to-Target of Rheumatoid Arthritis in Real World Practice: Data from the International Rheumatoid Arthritis Biomarker Program. 2014
Leflunomide Use Is Not Associated with an Increased Risk of Lung Disease in Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials 2014
Osteoporotic Women at High Risk for Fractures Despite Two Years of Oral Bisphosphonate Therapy: Analysis Using the Canadian Multicentre Osteoporosis Study 2014
Patient Perspectives on the Introduction of Subsequent Entry Biologics in Canada. 2014
Predictors of ACR/EULAR Boolean and SDAI Remission in Patients with Established Rheumatoid Arthritis Treated with Anti-TNF: An Analysis from the Prospective, Observational, Biological Treatment Registry Across Canada 2014
Quality of Primary Care Management of Patients with and without Rheumatoid Arthritis (RA) 2014
Resident's Guide to Rheumatology Mobile Application: An International Needs Assessment. 2014
The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis 2014
The Relationship of ARMS2 Genotype with Idiopathic Inflammatory Vasculitis. 2014
The Relationship of Quadriceps and Hamstrings Intramuscular Fat and Lean Muscle with Power in Women with Knee Osteoarthritis. 2014
The Role of Macrophage Migration Inhibitory Factor (MIF) and MIF Gene Polymorphisms in the Pathogenesis of Granulomatosis with Polyangiitis. 2014
Training the Rheumatologists of Tomorrow: The Canadian Experience. 2014
Using Patient Reported Outcome Measures to Classify Disease Activity States in Rheumatoid Arthritis: A Comparison of Patient Activity Score (PAS) and Routine Assessment of Patient Index Data (RAPID) 2014
Using Patient Reported Outcome Measures to Classify Disease Activity States in Rheumatoid Arthritis: A Comparison of Patient-Derived Versions of Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI) and Disease Activity Score 28 (DAS28) 2014
Validation of Snapshot, a Rheumatoid Arthritis Assessment Tool, Against CDAI, DAS28 (ESR), and DAS28 (CRP) in Canadian Patients with Rheumatoid Arthritis 2014
Vasculitis and Inflammatory Bowel Diseases: A Study of 32 Patients with Both Conditions and Systematic Review of the Literature. 2014
Venothromboembolism in Large Vessel Vasculitis. 2014
Why Doesn't Participation in Activity Increase Following Hip or Knee Replacement? 2014
A144: Resident's Guide to Rheumatology Guide Mobile Application: An International Needs Assessment 2014
A154: Glucocorticoid Therapy and the Risk of Incident Vertebral Fracture in Children with Rheumatic Disorders 2014
A24: Validation of BASDAI and BASFI in Children with Spondyloarthritis 2014
Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids. 76:1431-1438. 2024
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. 76:1201-1213. 2024
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. 76:1182-1200. 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study. 76:1120-1129. 2024
2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. 75:2088-2102. 2023
The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA‐Associated Vasculitis. 75:2216-2227. 2023
2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate‐to‐Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective. 75:1877-1888. 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria. 75:1687-1702. 2023
2022 American College of Rheumatology Guideline for Exercise, Rehabilitation, Diet, and Additional Integrative Interventions for Rheumatoid Arthritis. 75:1299-1311. 2023
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. 75:333-348. 2023
2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. 74:1881-1889. 2022
2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.. 81:1654-1660. 2022
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease. 74:586-596. 2022
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids. 74:604-611. 2022
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. 74:386-392. 2022
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis.. 81:315-320. 2022
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis.. 81:321-326. 2022
Association of Machine Learning–Based Predictions of Medial Knee Contact Force With Cartilage Loss Over 2.5 Years in Knee Osteoarthritis. 73:1638-1645. 2021
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. 73:1366-1383. 2021
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. 73:1349-1365. 2021
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa. 73:1384-1393. 2021
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. 73:1108-1123. 2021
Sequence‐Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2. 73:512-519. 2021
Health Assessment Questionnaire at One Year Predicts All‐Cause Mortality in Patients With Early Rheumatoid Arthritis. 73:197-202. 2021
2020 American College of Rheumatology Guideline for the Management of Gout. 72:879-895. 2020
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. 72:529-556. 2020
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. 72:220-233. 2020
Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial. 71:1174-1184. 2019
Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study. 71:878-891. 2019
Pain Susceptibility Phenotypes in Those Free of Knee Pain With or at Risk of Knee Osteoarthritis: The Multicenter Osteoarthritis Study. 71:542-549. 2019
Presentation and Disease Course of Childhood‐Onset Versus Adult‐Onset Takayasu Arteritis. 71:315-323. 2019
2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. 71:5-32. 2019
Utilization and Short‐Term Outcomes of Primary Total Hip and Knee Arthroplasty in the United States and Canada. 70:547-554. 2018
2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis. 69:1521-1537. 2017
2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty. 69:1538-1551. 2017
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort. 69:1067-1077. 2017
Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis. 69:1054-1066. 2017
A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Giant Cell Arteritis. 69:837-845. 2017
A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis. 69:846-853. 2017
Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials. 69:362-375. 2017
Reply. 69:477-478. 2017
High‐Resolution Magnetic Resonance Imaging of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Cohort Study. 69:161-168. 2017
Editorial: Extracellular Matrix: The Common Thread of Disease Progression in Fibrosis?. 68:1053-1056. 2016
2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. 68:1-26. 2016
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. 68:282-298. 2016
Release of Neutrophil Extracellular Traps by Neutrophils Stimulated With Antiphospholipid Antibodies: A Newly Identified Mechanism of Thrombosis in the Antiphospholipid Syndrome. 67:2990-3003. 2015
Identification of Susceptibility Loci in IL6, RPS9/LILRB3, and an Intergenic Locus on Chromosome 21q22 in Takayasu Arteritis in a Genome‐Wide Association Study. 67:1361-1368. 2015
Intraarticular Hip Injection and Early Revision Surgery Following Total Hip Arthroplasty: A Retrospective Cohort Study. 67:162-168. 2015
Reply. 66:2642-2642. 2014
Tocilizumab Treatment Leads to a Rapid and Sustained Increase in Treg Cell Levels in Rheumatoid Arthritis Patients: Comment on the Article by Thiolat et al. 66:2638-2638. 2014
Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Controlled Trials. 66:803-812. 2014
The Epidemiology of Rheumatoid Arthritis in Ontario, Canada. 66:786-793. 2014
Distinct Phenotype Clusters in Childhood Inflammatory Brain Diseases: Implications for Diagnostic Evaluation. 66:750-756. 2014
Increased Surgeon Experience With Rheumatoid Arthritis Reduces the Risk of Complications Following Total Joint Arthroplasty. 66:488-496. 2014
Increased Risk of Complications Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis. 66:254-263. 2014

Arthritis & Rheumatology Journal

Overview

publication venue for

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)